bpc 157 knee injection human study 12 patients BPC-157 For Pain: Early Reported Outcomes A report on intra-articular BPC-157 for knee pain described high rates of improvement: ~92% with BPC-157 alone, ~75% when combined with thymosin beta-4, and overall BPC-157: Tendon Repair and More
Description
Neither approach helps you make informed decisions about your research

Is BPC-157 better as a capsule or injection

Mounjaro is typically initiated at 2.5 mg weekly for 4 weeks, then increased to 5 mg for at least 4 weeks

Its the subject of ongoing studies
